# FDA 483 - Laurie Mereu, MD - Unknown Date

Source: https://www.globalkeysolutions.net/records/483/laurie-mereu-md/2c02f04c-2b64-4928-8157-2e6c5a09363e

> FDA 483 for Laurie Mereu, MD on Unknown Date. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Laurie Mereu, MD
- Product Type: drugs
- Office Name: Philadelphia District Office
- Summary: An FDA inspection of the Division of Endocrinology & Metabolism, Dept. of Medicine in Edmonton, AB, Canada, from July 18-22, 2016, revealed that an investigation was not conducted in accordance with the investigational plan. Specifically, subjects were randomized into a study without the most recent serum creatinine and eGFR results, and temperature monitoring for clinical supplies storage was not consistently performed over several months.

## Related Officers

- [investigator](https://www.globalkeysolutions.net/people/marcelo-o-mangalindan-jr/9fe13d26-0c5e-4559-be36-812970fa67ce)

Company: https://www.globalkeysolutions.net/companies/laurie-mereu-md/a60f9221-a36e-4716-9b5a-3bcccda12d16

Office: https://www.globalkeysolutions.net/offices/philadelphia-district-office/c5ec7398-b3d5-4125-9793-fb7b972578d8